British Journal of Clinical Pharmacology · 1982 · 28 citations · 12 references
MedicineBiochemistryPharmacologyFertilityReproductive BiologyReproductive PhysiologyMale InfertilityReproductive PharmacologySperm FunctionSperm Membrane IntegritySperm Motility AssessmentInterferencePlasma Membrane StabilizationSolubilitySperm Function AssessmentSperm Function InhibitionSperm Membrane PhysiologySperm Membrane StabilizationSperm Plasma Membrane Stability
1 Sperm immobilizing effects of five beta-adrenoceptor blockers were measured on six human semen samples with a trans-membrane migration method. 2 The concentrations which decreased sperm motility to 50% of control (ED50) were 0.8, 4.2, 6.2, 11.0 and 33.0 mM for propranolol, oxprenolol, metoprolol, acebutolol and sotalol respectively. 3 There was a linear correlation between the log values of ED50 and the log partition coefficients of these beta-adrenoceptor blockers. 4 Because the lipid solubility determines the sperm immobilizing potencies of beta-adrenoceptor blockers, we support the theory that beta-adrenoceptor blockers inhibit sperm motility by stabilizing the cellular membrane. 5 The clinical implication of this finding is that more lipid soluble drugs are likely to have more interference on sperm function, at least when they are used locally.
12
D. Hellenbrecht, Björn Lemmer, G. Wiethold et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1973 · 148 citations
D-propranolol and DL-propranolol both decrease conversion of L-thyroxine to L-triiodothyronine.
P Heyma, Richard G. Larkins, Linda Higginbotham et al. · BMJ · 1980 · 64 citations · Full text